Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $472.05 -3.55%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 53
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 53
Join SI Premium – FREE
Ladenburg Thalmann downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Neutral.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $104.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Starts United Therapeutics Corp. (UTHR) at Sell
- JPMorgan Downgrades Tanger Factory Outlet Centers (SKT) to Neutral
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
